Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,310
archived clinical trials in
Allergy

Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated:  12/31/1969
Cara Therapeutics Study Site
mi
from
Augusta, GA
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated: 12/31/1969
Cara Therapeutics Study Site
mi
from
Augusta, GA
Click here to add this to my saved trials
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated:  12/31/1969
Cara Therapeutics Study Site
mi
from
Meridian, ID
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated: 12/31/1969
Cara Therapeutics Study Site
mi
from
Meridian, ID
Click here to add this to my saved trials
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated:  12/31/1969
Cara Therapetics Study Site
mi
from
Creve Coeur, MO
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated: 12/31/1969
Cara Therapetics Study Site
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated:  12/31/1969
Cara Therapeutics Study Site
mi
from
Omaha, NE
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated: 12/31/1969
Cara Therapeutics Study Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated:  12/31/1969
Cara Therapetics Investigator Site
mi
from
Albuquerque, NM
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated: 12/31/1969
Cara Therapetics Investigator Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated:  12/31/1969
Cara Therapeutics Investigator Site
mi
from
Mineola, NY
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated: 12/31/1969
Cara Therapeutics Investigator Site
mi
from
Mineola, NY
Click here to add this to my saved trials
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated:  12/31/1969
Cara Therapeutics Investigator Site
mi
from
Wilmington, NC
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated: 12/31/1969
Cara Therapeutics Investigator Site
mi
from
Wilmington, NC
Click here to add this to my saved trials
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated:  12/31/1969
Cara Therapeutics Study Site
mi
from
Winston-Salem, NC
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated: 12/31/1969
Cara Therapeutics Study Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated:  12/31/1969
Cara Therapeutics Study Site
mi
from
Bethlehem, PA
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated: 12/31/1969
Cara Therapeutics Study Site
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated:  12/31/1969
Cara Therapeutics Investigator Site
mi
from
Philadelphia, PA
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling
Updated: 12/31/1969
Cara Therapeutics Investigator Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Andover, MA
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Andover, MA
Click here to add this to my saved trials
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Memphis, TN
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Arkansas Children's Hospital
mi
from
Little Rock, AR
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Allergy and Asthma Associates of Southern California
mi
from
Mission Viejo, CA
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Allergy and Asthma Associates of Southern California
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Palos Verdes Medical Group
mi
from
Rolling Hills Estates, CA
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Palos Verdes Medical Group
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
National Jewish Health
mi
from
Denver, CO
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Sarasota Clinical Research
mi
from
Sarasota, FL
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Sarasota Clinical Research
mi
from
Sarasota, FL
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Atlanta Allergy & Asthma Clinic, PA
mi
from
Marietta, GA
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Atlanta Allergy & Asthma Clinic, PA
mi
from
Marietta, GA
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Sneeze, Wheeze and Itch Associates,Clinical Research
mi
from
Normal, IL
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Sneeze, Wheeze and Itch Associates,Clinical Research
mi
from
Normal, IL
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Institute Inc
mi
from
Plymouth, MN
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Institute Inc
mi
from
Plymouth, MN
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
The Asthma & Allergy Center, PC
mi
from
Bellevue, NE
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
The Asthma & Allergy Center, PC
mi
from
Bellevue, NE
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
National Allergy and Asthma Research, LLC
mi
from
Charleston, SC
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
National Allergy and Asthma Research, LLC
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Children's Medical Center of Dallas
mi
from
Dallas, TX
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Children's Medical Center of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine/Texas Children's Hospital
mi
from
Houston, TX
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine/Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Sylvana Research
mi
from
San Antonio, TX
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Sylvana Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
STAAMP Research
mi
from
San Antonio, TX
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
STAAMP Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
ASTHMA, Inc. Clinical Research
mi
from
Seattle, WA
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
ASTHMA, Inc. Clinical Research
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Children's and Women's Health Centre of Brisith Columbia
mi
from
Vancouver,
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Children's and Women's Health Centre of Brisith Columbia
mi
from
Vancouver,
Click here to add this to my saved trials
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
University of North Carolina Chapell Hill
mi
from
Chapel Hill, NC
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
University of North Carolina Chapell Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
John Hopkins Hospital University-Divison of Pediatric Allergy
mi
from
Baltimore, MD
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
John Hopkins Hospital University-Divison of Pediatric Allergy
mi
from
Baltimore, MD
Click here to add this to my saved trials
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
UNC Rheumatolory Allergy & Immunology Clinic
mi
from
Chapel Hill, NC
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
UNC Rheumatolory Allergy & Immunology Clinic
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Inflamax Research Limited
mi
from
Mississauga,
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Inflamax Research Limited
mi
from
Mississauga,
Click here to add this to my saved trials
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Allergy, Asthma and Immunology Center
mi
from
Tulsa, OK
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Allergy, Asthma and Immunology Center
mi
from
Tulsa, OK
Click here to add this to my saved trials
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
South Texas Allergy & Asthma Medical Professionals (STAAMP)
mi
from
San Antonio, TX
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
South Texas Allergy & Asthma Medical Professionals (STAAMP)
mi
from
San Antonio, TX
Click here to add this to my saved trials
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
ASTHMA, Inc.
mi
from
Seattle, WA
HAL-MPE1 Safety and Tolerability Study
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
ASTHMA, Inc.
mi
from
Seattle, WA
Click here to add this to my saved trials
Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy
Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
Stanford University Medical Center
mi
from
Palo Alto, CA
Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy
Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
Stanford University Medical Center
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy
Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy
Status: Enrolling
Updated:  12/31/1969
ASTHMA Inc. Clinical Research Center
mi
from
Seattle, WA
Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy
Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy
Status: Enrolling
Updated: 12/31/1969
ASTHMA Inc. Clinical Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children
Open-label Follow-up Study of the PEPITES Study to Evaluate the Long-term Efficacy and Safety of Viaskin Peanut
Status: Enrolling
Updated:  12/31/1969
Arkansas Children's Hospital
mi
from
Little Rock, AR
Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children
Open-label Follow-up Study of the PEPITES Study to Evaluate the Long-term Efficacy and Safety of Viaskin Peanut
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children
Open-label Follow-up Study of the PEPITES Study to Evaluate the Long-term Efficacy and Safety of Viaskin Peanut
Status: Enrolling
Updated:  12/31/1969
University of California, Rady Childrens Hospital
mi
from
San Diego, CA
Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children
Open-label Follow-up Study of the PEPITES Study to Evaluate the Long-term Efficacy and Safety of Viaskin Peanut
Status: Enrolling
Updated: 12/31/1969
University of California, Rady Childrens Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials